Haemonetics (HAE)
(Delayed Data from NYSE)
$75.08 USD
-0.41 (-0.54%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $75.08 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth F Momentum F VGM
Haemonetics (HAE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$108.67 | $125.00 | $85.00 | 43.95% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Haemonetics comes to $108.67. The forecasts range from a low of $85.00 to a high of $125.00. The average price target represents an increase of 43.95% from the last closing price of $75.49.
Analyst Price Targets (9 )
Broker Rating
Haemonetics currently has an average brokerage recommendation (ABR) of 1.78 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the nine recommendations deriving the current ABR, four are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 44.44% and 33.33% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 3 |
Buy | 3 | 3 | 2 | 2 | 2 |
Hold | 2 | 2 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.78 | 1.78 | 1.67 | 1.67 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/13/2024 | C.L. King & Associates | Kristen M Stewart | Not Available | Moderate Buy |
9/10/2024 | BTIG | Marie Thibault | Not Available | Strong Buy |
8/22/2024 | Not Identified | Not Identified | Hold | Hold |
8/13/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
8/9/2024 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
6/21/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
6/12/2024 | Needham & Company | Michael Matson | Hold | Moderate Buy |
5/13/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.78 |
ABR (Last week) | 1.78 |
# of Recs in ABR | 9 |
Average Target Price | $108.67 |
LT Growth Rate | 14.00% |
Industry | Medical - Products |
Industry Rank by ABR | 70 of 253 |
Current Quarter EPS Est: | 1.09 |
HAE FAQs
Haemonetics Corporation (HAE) currently has an average brokerage recommendation (ABR) of 1.78 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Haemonetics Corporation (HAE) is $108.67. The current on short-term price targets is based on 5 reports.
The forecasts for Haemonetics Corporation (HAE) range from a low of $85 to a high of $125. The average price target represents a increase of $44.74 from the last closing price of $75.08.
The current UPSIDE for Haemonetics Corporation (HAE) is 44.74%
Based on short-term price targets offered by nine analysts, the average price target for Haemonetics comes to $108.67. The forecasts range from a low of $85.00 to a high of $125.00. The average price target represents an increase of 43.95% from the last closing price of $75.49.